Narrows Institute for Biomedical Research
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Narrows Institute for Biomedical Research sits in the upper quartile of US sponsors by registered trial count (#2,411 of 15,742 sponsors by registered trial count).
Narrows Institute for Biomedical Research: 5 sponsored US clinical trials, 1 recruiting.
Narrows Institute for Biomedical Research sponsors 5 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 4 completed. 0 of these trials are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Post-inflammatory Hyperpigmentation, with 1 trials.
Upper-quartile sponsor footprint
Narrows Institute for Biomedical Research sits in the upper quartile of the sponsor corpus (#2,411 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
5 total, page 1 of 1
Efficacy and Safety of Topical Clascoterone (WINLEVI) Cream 1% in Patients With Facial Acneiform Rosacea
NCT06952517
Evaluating the Safety and Efficacy of Topical Sirolimus 0.2% to Treat Acanthosis Nigricans
NCT06940895
A Novel Regimen for Treatment and Prevention of Post-Inflammatory Hyperpigmentation in Skin of Color
NCT06938815
TACTICS (Targeting Adherence to Cholesterol-lowering Therapy to Improve Control Study)
NCT01043354
The PREVENTS Trial: The Preventing Recurrent Events in Veterans Navigating Transient Ischemic Attack (TIA) or Stroke Trial
NCT01020851
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 2 |
Therapeutic Areas
What is open in the Narrows Institute for Biomedical Research pipeline
1 recruiting of 5 indexed (20% open); 4 completed (80%).
Phase mix: 0 late (III/IV) vs 2 early (I/II) (early-phase heavy).
Top condition: Post-inflammatory Hyperpigmentation (1 trial), 3 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Narrows Institute for Biomedical Research: open-pipeline peers nationwide
Peers matched on 5 registered trials and 20% open enrollment, not the therapeutic-area sidebar.
Narrows Institute for Biomedical Research sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 5 trials (± recruiting share)
- 4YouandMe · 5 trials · 0% recruiting
- Abbott Rapid Dx · 5 trials · 0% recruiting
- Access Business Group · 5 trials · 0% recruiting
- Acera Surgical · 5 trials · 20% recruiting
Sponsors near 20% open enrollment (± trial volume)
- Align Technology · 20% recruiting · 5 trials
- AltruBio · 20% recruiting · 5 trials
- Alvernia University · 20% recruiting · 5 trials
- Amazentis · 20% recruiting · 5 trials
Related
What to do with this Narrows Institute for Biomedical Research page
5 registered trials is a research-attention snapshot, not an endorsement of Narrows Institute for Biomedical Research or any single study.
- 1 of Narrows Institute for Biomedical Research's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Post-inflammatory Hyperpigmentation is the condition Narrows Institute for Biomedical Research studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Post-inflammatory Hyperpigmentation trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Narrows Institute for Biomedical Research pipeline card: 5 registered trials from official public datasets.Report a data error.